Apr 14
|
Pfizer drops obesity pill development after liver injury report
|
Apr 14
|
Top Midday Stories: Stocks Rally on Tariff Exemption News; Pfizer Discontinues Development of Weight-Loss Drug
|
Apr 14
|
Pfizer's $130B Weight-Loss Dream Just Collapsed
|
Apr 14
|
Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk.
|
Apr 14
|
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
|
Apr 14
|
Pfizer just had a big setback in its race for an Ozempic competitor
|
Apr 14
|
Pfizer, Nvidia, Intel: Stocks in 30
|
Apr 14
|
Pfizer Halts Development of Weight-Loss Pill
|
Apr 14
|
Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds?
|
Apr 14
|
Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury'
|
Apr 14
|
Pfizer Abandons Obesity Pill After Trial Liver Injury
|
Mar 28
|
Genmab’s Tivdak approved in Japan for advanced cervical cancer
|
Mar 27
|
Sector Update: Health Care Stocks Advance Late Afternoon
|
Mar 27
|
Update: Sen. Ron Wyden Accuses Pfizer of Tax Dodging After Concluding Investigation
|
Mar 27
|
Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive
|
Mar 27
|
GSK accuses Pfizer of delaying Covid vaccine result until after US election
|
Mar 27
|
Is Pfizer Inc.'s (NYSE:PFE) Recent Price Movement Underpinned By Its Weak Fundamentals?
|
Mar 27
|
Update: Market Chatter: US Prosecutors Investigate Tip on Pfizer Vaccine
|
Mar 27
|
Why Pfizer Is My Largest Healthcare Position
|
Mar 27
|
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks
|